100 participants
A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-26
- Start Date:
- 2025-03-05
- Completion:
- 2027-01-31
Conditions
- B-Cell Non-Hodgkins Lymphoma
Interventions
- DRUG
No Results Yet